Bunkerhill ECG-EF vs AI-ECG Platform

Direct competitors — feature-level head-to-head below. Comparability 80/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by BunkerHill Health
VS
by Shenzhen Carewell Electronics Co., Ltd.

AI Verdict

Both tools are FDA-cleared AI solutions designed for analyzing 12-lead ECGs in cardiology. Tool A specializes in detecting reduced left ventricular ejection fraction to identify heart failure risk, while Tool B offers a broader AI-powered analysis and diagnosis system for a wider range of cardiovascular conditions. Therefore, while both are direct competitors in the ECG AI space, their specific diagnostic focus areas differ.

Choose Bunkerhill ECG-EF if…

Choose Bunkerhill ECG-EF if your primary goal is the early and automated identification of patients at risk for heart failure by specifically detecting reduced left ventricular ejection fraction (LVEF ≤ 40%) from routine 12-lead ECGs. This tool is ideal for seamless integration into existing EHRs and clinical archives to support proactive screening workflows for heart failure.

View Bunkerhill ECG-EF →

Choose AI-ECG Platform if…

Choose AI-ECG Platform if you require a comprehensive AI-powered system for automatic analysis and diagnosis across a broad range of cardiovascular diseases, including arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction. This platform is well-suited for assisting physicians with rapid and accurate interpretation of 12-lead resting ECGs, offering flexible deployment options like workstations or web-based portals for professional review.

View AI-ECG Platform →

When choosing between Bunkerhill ECG-EF and the AI-ECG Platform, physicians should consider their primary need. Bunkerhill ECG-EF excels at a singular, critical task: identifying reduced left ventricular ejection fraction (LVEF ≤ 40%) from routine 12-lead ECGs. This makes it a highly specialized tool for early identification of patients at risk for heart failure, seamlessly integrating with existing EHRs and clinical archives to support automated workflows. Its focus is on a specific, actionable cardiac condition, offering a non-invasive, rapid, and accessible diagnostic aid.

In contrast, the AI-ECG Platform offers a broader, more comprehensive AI-powered automatic analysis and diagnosis of 12-lead resting ECGs. It diagnoses a wider range of conditions, including arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction, with reported accuracy over 95% for major cardiovascular diseases. The key practical difference lies in their scope: Bunkerhill ECG-EF is a targeted solution for LVEF detection, while the AI-ECG Platform provides a more general diagnostic assistant for various ECG abnormalities. Physicians primarily focused on early heart failure risk stratification would find Bunkerhill ECG-EF more aligned with their needs. Those seeking a versatile AI tool to assist in the interpretation of a broad spectrum of ECG findings should consider the AI-ECG Platform, which also offers flexible deployment options including workstation, web-based, and Windows-based clients.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Bunkerhill ECG-EF AI-ECG Platform
Pricing Contact for pricing Contact for pricing
Deployment Integrates seamlessly with EHRs and clinical archives. Workstation (with GPU), web-based portal, Windows-based diagnostic client
BAA Available Yes AI-estimated Unknown
FDA Status Yes AI-estimated 1 AI-estimated
HIPAA Yes AI-estimated Unknown

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Bunkerhill ECG-EF AI-ECG Platform
Name Bunkerhill ECG-EF AI-ECG Platform
Company BunkerHill Health Shenzhen Carewell Electronics Co., Ltd.
Description FDA-cleared artificial intelligence algorithm that detects reduced left ventricular ejection fraction (LVEF u2264 40%) from routine 12-lead electrocardiograms (ECGs), aiding in the early identification of patients at risk for heart failure. FDA-cleared artificial intelligence (AI) automatic analysis and diagnosis system for ECG, designed to assist physicians in interpreting 12-lead resting ECGs with high accuracy.
Key Functionality AI algorithm to detect reduced Left Ventricular Ejection Fraction (LVEF u2264 40%) AI-powered automatic ECG analysis and diagnosis
Specialties Cardiology, Emergency Medicine, Internal Medicine Cardiology, Emergency Medicine, Internal Medicine
Analysis Speed Not specified Rapid diagnosis in approximately 3 seconds

Videos

Demos, reviews, and walkthroughs featuring Bunkerhill ECG-EF and AI-ECG Platform.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Bunkerhill ECG-EF (Tool A) is an AI algorithm specifically designed to detect reduced left ventricular ejection fraction (LVEF u2264 40%) from routine 12-lead ECGs, aiding in the early identification of patients at risk for heart failure. The AI-ECG Platform (Tool B) provides AI-powered automatic analysis and diagnosis for 12-lead resting ECGs, assisting physicians in interpreting and diagnosing arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction.
Bunkerhill ECG-EF (Tool A) integrates seamlessly with EHRs and clinical archives, functioning as a software-only medical device that connects with Electronic Medical Records (EMR) or ECG Management Systems (EMS). The AI-ECG Platform (Tool B) offers deployment options including a workstation (with GPU), a web-based portal, and a Windows-based diagnostic client, and is hardware independent, compatible with most ECG machines.
Bunkerhill ECG-EF (Tool A) aids in the early identification of patients at risk for heart failure by detecting reduced LVEF. The AI-ECG Platform (Tool B) claims over 95% accuracy in diagnosing major cardiovascular diseases, including arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction.
Bunkerhill ECG-EF (Tool A) analyzes routine 12-lead ECG data and integrates with EMR or ECG Management Systems. The AI-ECG Platform (Tool B) supports various ECG data formats including Carewell ECG, HL7 aECG, DICOM ECG, SCP ECG, and MFER ECG.
Bunkerhill ECG-EF (Tool A) is described as a non-invasive, rapid, and accessible cardiac diagnostic tool. The AI-ECG Platform (Tool B) provides rapid diagnosis in approximately 3 seconds.
AI Tool Finder
AI-powered search. Results may not be comprehensive.